Loading company details...
Latest Form 4 (Nov 16, 2026): Raymond George Hill (Director): Grant/Award of 1,319,996 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Raymond George Hill | Grant/Award | 1,319,996 | n/a |
| Nov 16, 2026 | Vincent Michael Lawton | Grant/Award | 1,885,708 | n/a |
| Nov 13, 2026 | Roger Mills, CHIEF MEDICAL OFFICER | Grant/Award | 942,854 | n/a |
| Nov 13, 2026 | Lenaic Nathanael Teyssedou, PRINCIPAL ACCOUNTING OFFICER | Grant/Award | 3,771,415 | n/a |
| Nov 13, 2026 | Jason Raleigh Nunn | Grant/Award | 942,854 | n/a |
| Nov 13, 2026 | Isaac Manke | Grant/Award | 942,854 | n/a |
| Nov 13, 2026 | Timothy Mark Dyer, CHIEF EXECUTIVE OFFICER | Grant/Award | 18,857,075 | n/a |
| Sep 4, 2026 | Lenaic Nathanael Teyssedou, PRINCIPAL ACCOUNTING OFFICER | Disposition to Issuer | 37,770 | n/a |
| Sep 4, 2026 | Mikhail Kalinichev, HEAD OF TRANSLATIONAL SCIENCE | Disposition to Issuer | 306,765 | n/a |
| Sep 4, 2026 | Jason Raleigh Nunn | Disposition to Issuer | 219,561 | n/a |